epirubicin has been researched along with Granuloma Gangraenescens in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avilés, A; Delgado, S; Fernández, A; Nambo, MJ; Rosas, A | 1 |
1 trial(s) available for epirubicin and Granuloma Gangraenescens
| Article | Year |
|---|---|
Combined therapy for angioimmunoproliferative lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Granuloma, Lethal Midline; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1994 |